1. Home
  2. LUNG vs JFU Comparison

LUNG vs JFU Comparison

Compare LUNG & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • JFU
  • Stock Information
  • Founded
  • LUNG 1995
  • JFU 2006
  • Country
  • LUNG United States
  • JFU China
  • Employees
  • LUNG N/A
  • JFU N/A
  • Industry
  • LUNG Industrial Specialties
  • JFU Finance: Consumer Services
  • Sector
  • LUNG Health Care
  • JFU Finance
  • Exchange
  • LUNG Nasdaq
  • JFU Nasdaq
  • Market Cap
  • LUNG 63.6M
  • JFU 58.2M
  • IPO Year
  • LUNG 2020
  • JFU 2019
  • Fundamental
  • Price
  • LUNG $1.41
  • JFU $4.55
  • Analyst Decision
  • LUNG Buy
  • JFU
  • Analyst Count
  • LUNG 7
  • JFU 0
  • Target Price
  • LUNG $6.81
  • JFU N/A
  • AVG Volume (30 Days)
  • LUNG 7.0M
  • JFU 7.5K
  • Earning Date
  • LUNG 11-12-2025
  • JFU 12-09-2022
  • Dividend Yield
  • LUNG N/A
  • JFU N/A
  • EPS Growth
  • LUNG N/A
  • JFU 3110.57
  • EPS
  • LUNG N/A
  • JFU 3.04
  • Revenue
  • LUNG $91,664,000.00
  • JFU $44,573,690.00
  • Revenue This Year
  • LUNG $10.41
  • JFU N/A
  • Revenue Next Year
  • LUNG $10.98
  • JFU N/A
  • P/E Ratio
  • LUNG N/A
  • JFU $1.48
  • Revenue Growth
  • LUNG 15.59
  • JFU 8.19
  • 52 Week Low
  • LUNG $1.35
  • JFU $1.01
  • 52 Week High
  • LUNG $9.37
  • JFU $5.88
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.77
  • JFU 50.98
  • Support Level
  • LUNG $1.65
  • JFU $4.45
  • Resistance Level
  • LUNG $2.11
  • JFU $4.82
  • Average True Range (ATR)
  • LUNG 0.17
  • JFU 0.26
  • MACD
  • LUNG -0.05
  • JFU -0.12
  • Stochastic Oscillator
  • LUNG 7.24
  • JFU 17.46

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.

Share on Social Networks: